SABCS 40th Annual Meeting

11/30/17

The 40th Annual San Antonio Breast Cancer Symposium will take place from December 5-9 in the Henry B Gonzalez Convention Center. Breast cancer clinicians and researchers will convene to discuss cutting-edge treatment options and novel strategies for managing breast cancer. Journal of Clinical Pathways will be highlighting many of the key presentations from the meeting.


triple negative

Untreated Elderly Patients Experience Higher Mortality Rates After Triple-Negative Diagnosis

Elderly patients with untreated early-stage triple-negative breast cancer exhibited a higher mortality rate than patients treated with neoadjuvant or adjuvant therapy.

Read More

 

 

brain

Brain Metastasis Commonly Seen in Women With HER2-Positive, Triple-Negative Breast Cancer

Women with HER2-positive and triple-negative breast cancer have an elevated risk of developing brain metastasis regardless of active systemic treatment receipt.

Read More

 

surgery

Surgical Re-Excision Rates Drop Following Breast-Conserving Surgery Guidelines

Re-excision rates following breast-conserving surgery have significantly declined in the wake of professional society guideline implementation.

Read More

 

 

 

chemo

Concurrent, Sequential Trastuzumab Does Not Impact OS, RFS in HER2-Positive Breast Cancer

Women with HER2-positive breast cancer who received sequential trastuzumab did not experience a significant difference in OS or RFS when compared with women who received concurrent therapy.

Read More


 

 

cost

Digital Breast Tomosynthesis Largely Cost Effective Compared with Digital Mammography

The use of digital breast tomosynthesis decreased false positive rates while increasing true negative rates when compared with traditional digital mammography.

Read More

 

 

 

 

 

black

Survival Outcomes Differ Among Black, White Women Treated With Neoadjuvant Chemotherapy

Non-Hispanic black patients with localized breast cancer who received neoadjuvant chemotherapy experienced worse distant relapse-free survival outcomes when compared with non-Hispanic white patients.

Read More

 

 

 
Nearly one in five women with early-stage breast cancer received guideline-discordant treatment, usually with regards to chemotherapy use.
 
 
 
 
 

risk

Reduced Breast Cancer Risk Associated With Weight Loss in Postmenopausal Women

Weight loss was associated with a reduced risk for breast cancer among postmenopausal women.

Read More

 

 

 

radiation

Radiation Therapy Cost-Effective in Patients With Early-Stage Breast Cancer

Overall costs of radiation therapy for early-stage breast cancer do not burden the health care system when analyzed in relation to survival benefit.

Read More